Olema Pharmaceuticals
OLMA
122 hedge funds and large institutions have $301M invested in Olema Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 27 reducing their positions, and 29 closing their positions.
111% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 27
21% more capital invested
Capital invested by funds: $248M → $301M (+$52.5M)
6.64% more ownership
Funds ownership: 96.44% → 103.08% (+6.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 133 → 122 (-11)
10% less call options, than puts
Call options by funds: $202K | Put options by funds: $225K
38% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$13.5M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$9.04M |
| 3 |
Morgan Stanley
New York
|
+$4.39M |
| 4 |
BlackRock
New York
|
+$3.49M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.55M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.42M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$2.46M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.61M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.37M |
OLMA Hedge Fund Activity: Q2 2025 in Review
122 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q2 2025, worth a combined $301M — up 21% from $248M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of OLMA and 18 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 57 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $13.5M. The largest seller was Wellington Management Group, cutting an estimated $5.55M.
- 122 institutional investors held Olema Pharmaceuticals (OLMA) as of Q2 2025, down from 133 in Q1 2025.
- Funds reported $301M of Olema Pharmaceuticals stock for Q2 2025, up 21% quarter-over-quarter.
- 18 funds opened new Olema Pharmaceuticals positions in Q2 2025 and 29 closed out, a net change of -11 holders.
- The largest Olema Pharmaceuticals buyer in Q2 2025 was Janus Henderson Group, an estimated $13.5M added.
- The largest Olema Pharmaceuticals seller in Q2 2025 was Wellington Management Group, an estimated $5.55M sold.
Based on aggregated 13F filings for Q2 2025.